BIOCRATES expands management board: New Chief Technology Officer (CTO) Dr. Ralph Zahn

08-Dec-2010 - Austria

BIOCRATES Life Sciences AG has employed Dr. Ralph Zahn as new CTO (Chief Technology Officer), since October 2010. „The constant development of our products and the affiliated technical and scientific assignments made a CTO necessary. Dr. Zahn and his expertise are a valuable enrichment to our organisation“, says Elgar Schnegg, MBA, CEO of BIOCRATES.

He holds a PhD in natural sciences and has a wealth of experience in the field of biotech. After he graduated from biology, he worked as research associate and earned the doctors degree in 1994 at the Max-Planck-Institute for Biochemistry in Munich. At the Cambridge University he absolved a post-graduate doctors degree. He habilitated 2001 at the Institute for Molecular Biology and Biophysics at the Eidgenössische Technische Hochschule in Zurich. During his career, he was managing director at BioSafety GmbH and founder and CEO of allprion AG.

Other news from the department people

More news from our other portals

All FT-IR spectrometer manufacturers at a glance

Last viewed contents